Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe Study Details page now indicates that recruitment is closed, and several navigation/help sections were added or clarified to improve access to the study information.SummaryDifference0.5%

- Check8 days agoChange DetectedThe page revision label has been updated to Revision: v3.5.5, replacing v3.5.4. This indicates a minor update to the page's revision history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a software or content revision. This update is a metadata change and does not modify the study details presented on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision indicator has been updated to a newer site/software version (from v3.5.2 to v3.5.3), without changing the displayed study details.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check86 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.